Data / Form D filings / Vesalius Longevity Labs Inc.
Vesalius Longevity Labs Inc.: Form D filing
Vesalius Longevity Labs Inc., a pharmaceuticals company in Vancouver, British Columbia, Canada, filed a Form D with the SEC in 2026. The latest, on November 3, 2026, reports $30.1 million sold of a $30.1 million offering to 62 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- SUITE 1500-1055 WEST GEORGIA STREET, Vancouver, British Columbia, Canada, V6E 4
- Phone
- (604) 307-8290
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2131865
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | New notice | $30,112,500 | $30,112,500 | 62 | Oct 28, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| PRADEEP ALBERT | Executive Officer | |
| CHRISTOPHER R COOPER | Executive Officer | |
| TIMMI STUMP | Executive Officer | |
| JAMES MCROBERTS | Director | |
| KEVIN SERRE | Director | |
| ROBERT MCCUE | Director | |
| JOEL LEONOFF | Director | |
| KEVIN MAYER | Director | |
| DAVID ADELMAN | Director | |
| LEE APPLBAUM | Director |
Every Form D from the week of Nov 2, 2026 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Vesalius Longevity Labs Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.